What are the interactions between Mycophenote (Cellcept) (Mycophenote Mofetil) and grapes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There is no significant interaction between mycophenolate (CellCept) and grapes that patients need to worry about. Unlike some medications that interact with grapefruit, mycophenolate can be safely taken with grapes or grape products. Mycophenolate is an immunosuppressant medication commonly used to prevent organ rejection after transplantation and to treat certain autoimmune conditions. The primary concern with mycophenolate is interactions with other medications rather than foods.

The medication works by inhibiting an enzyme called inosine monophosphate dehydrogenase, which reduces the proliferation of T and B lymphocytes. While patients taking mycophenolate should be careful about taking antacids, cholestyramine, or certain antibiotics within a few hours of their dose due to potential absorption issues, they can consume grapes freely without affecting the medication's efficacy or safety profile. As always, patients should take mycophenolate exactly as prescribed, typically on an empty stomach, and maintain consistent timing of doses for optimal results. According to the guidelines for the management of psoriasis and psoriatic arthritis 1, and the monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients 1, there is no mention of grape interaction, further supporting the safety of consuming grapes with mycophenolate.

Key points to consider when taking mycophenolate include:

  • Potential drug interactions with antacids, cholestyramine, or certain antibiotics
  • Increased risk of opportunistic infections and certain malignancies
  • Need for regular monitoring of blood cell counts, liver function, and kidney function
  • Importance of taking the medication exactly as prescribed to maintain optimal efficacy and safety. Patients should be aware of the potential side effects of mycophenolate, including gastrointestinal effects, hematologic effects, and increased risk of infections, as outlined in the guidelines 1.

From the Research

Interactions between Mycophenolate Mofetil and Grapes

There is no direct evidence of interactions between Mycophenolate Mofetil (Cellcept) and grapes in the provided studies.

Mechanism of Action and Pharmacokinetics

  • Mycophenolate mofetil is a prodrug that is rapidly hydrolyzed to mycophenolic acid after oral administration 2.
  • Mycophenolic acid inhibits de novo purine synthesis, resulting in antiproliferative effects on T and B lymphocytes 2.
  • The absolute bioavailability of mycophenolic acid is 94% for oral administration; the maximum plasma concentration occurs after two hours 2.

Adverse Effects and Interactions

  • The most common adverse effects of mycophenolate mofetil are gastrointestinal 2.
  • Mycophenolate mofetil may be linked to bone marrow suppression and certain malignancies 2.
  • There is no mention of interactions with grapes or any other food products in the provided studies.

Clinical Efficacy and Usage

  • Mycophenolate mofetil is used to prevent or treat allograft rejection after solid-organ transplantation 2, 3, 4, 5, 6.
  • Clinical trials of mycophenolate mofetil in renal transplant patients suggest that the drug is effective for the prevention of acute rejection and as rescue therapy 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mycophenolate mofetil: a unique immunosuppressive agent.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997

Research

Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity.

Transplant infectious disease : an official journal of the Transplantation Society, 2009

Research

The association of mycophenolate mofetil and human herpes virus infection.

The Journal of dermatological treatment, 2020

Research

Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.